The CuriOralRx oral biologics platform is broadly applicable across therapeutic areas where oral delivery can meaningfully improve outcomes, adherence, and quality of life compared with traditional injectable therapies.

Metabolic & Endocrine Disorders
Including oral insulin, oral GLP‑1, and combination therapies such as insulin plus pramlintide for diabetes and metabolic disease.

Inflammatory Diseases
Advancing oral biologic proteins and antibodies for conditions such as Crohn’s disease and inflammatory bowel disease (IBD).

Pediatric Growth & Development
Enabling child‑friendly, non‑invasive oral biologics aligned with pediatric growth and developmental therapies.

Enzyme Replacement & Rare Diseases
Expanding access to oral biologics for patients with rare and lifelong conditions requiring sustained treatment.

Age‑Related & Geriatric Conditions
Supporting safer, more convenient biologic therapies for aging populations requiring chronic care.